Cybin Newsroom

CCORF Maintains Cybin(CYBN.US) With Buy Rating, Maintains Target Price $86

Futu NewsNov 19 20:33

Optimistic Buy Rating for Cybin: Promising CYB003 Phase 2 Results and Market Potential

TipRanksNov 19 20:02

HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $190 Price Target

BenzingaNov 19 01:14

Cybin Is Maintained at Buy by Canaccord Genuity

Dow JonesNov 15 00:11

Cybin Analyst Ratings

BenzingaNov 15 00:04

CCORF Maintains Cybin(CYBN.US) With Buy Rating, Cuts Target Price to $86

Futu NewsNov 14 20:34

A. G. P. Initiates Cybin(CYBN.US) With Buy Rating, Announces Target Price $25

Futu NewsNov 14 20:34

Cybin's Promising Growth in the Psychedelic Sector Justifies Buy Rating

TipRanksNov 4 22:36

Strong Buy Rating for Cybin Inc. on Promising Clinical Advances and Strategic Management Positioning

TipRanksSep 24 16:18

Cybin Is Maintained at Buy by Canaccord Genuity

Dow JonesSep 23 23:23

Cybin Analyst Ratings

BenzingaSep 23 23:13

Cybin Analyst Ratings

BenzingaAug 23 19:27

Cybin's Promising Psychedelic Treatments Bolster Buy Rating and $5 Price Target

TipRanksAug 23 18:18

Cybin Analyst Ratings

BenzingaJul 31 20:11

HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $5 Price Target

BenzingaJul 31 20:11

Buy Rating Affirmed for Cybin Amid Advancements in Psychedelic Medicine and Strategic Regulatory Approaches

TipRanksJul 31 18:19

Cybin Analyst Ratings

BenzingaJun 22 00:33

HC Wainwright & Co. : Cybin (CYBN.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $5.00.

Zhitong FinanceMay 17 01:10

Cybin Analyst Ratings

BenzingaMay 17 01:10

HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $5 Price Target

BenzingaMay 17 01:10